Yes, HIV is a pandemic. It has spread across every continent and infected over 91 million people since it was first identified in the early 1980s, making it one of the most devastating pandemics in modern history. Around 39 to 41 million people are currently living with HIV worldwide, and 44.1 million have died from AIDS-related illnesses over the course of the epidemic.
What Makes HIV a Pandemic
The CDC defines a pandemic as an epidemic that has spread over several countries or continents, usually affecting a large number of people. An epidemic, by contrast, is a sudden increase in disease cases above what’s normally expected in a specific population or area. HIV easily meets the pandemic threshold: it is present in every region of the world and continues to produce new infections each year across dozens of countries.
You’ll sometimes see UNAIDS and other organizations refer to HIV as a “global epidemic” rather than a pandemic. This isn’t a contradiction. The terms overlap, and in practice, “global epidemic” and “pandemic” describe the same reality. The choice of language often reflects the messaging goals of the organization rather than a meaningful distinction in classification. Unlike COVID-19, which arrived suddenly and spread explosively, HIV established itself gradually over decades, which is one reason the word “pandemic” isn’t always front and center in public health communications about it.
Where HIV Hits Hardest
Although HIV is present globally, its burden is wildly uneven. More than half of all people living with HIV in 2024, roughly 21.1 million, live in eastern and southern Africa. Western and central Africa account for another 5.2 million. Asia and the Pacific hold 6.9 million cases, Latin America 2.5 million, and Western and Central Europe combined with North America about 2.4 million.
This concentration in sub-Saharan Africa reflects decades of compounding factors: limited early access to testing and treatment, higher rates of co-infections like tuberculosis, economic inequality, and social stigma that discouraged people from seeking care. In some countries within eastern and southern Africa, HIV prevalence among adults exceeds 20%, a level epidemiologists call “hyperendemic,” meaning the virus is persistently circulating at very high levels in the population.
How Treatment Changed the Trajectory
The HIV pandemic today looks nothing like it did in the 1990s, when an HIV diagnosis was effectively a death sentence. The turning point was antiretroviral therapy, which suppresses the virus to the point where it becomes undetectable in blood tests and, critically, untransmittable to sexual partners.
The evidence behind this is remarkably strong. In one landmark study, researchers followed 1,763 mixed-status couples (where one partner had HIV and the other didn’t) for a median of 5.5 years. Among couples where the HIV-positive partner was on treatment and had a suppressed viral load, zero linked sexual transmissions occurred. Three additional large studies tracked over 2,000 couples through more than 144,000 episodes of sex without condoms while the HIV-positive partner’s virus was suppressed. Again, not a single linked transmission. This body of evidence gave rise to the public health message known as U=U: Undetectable equals Untransmittable.
Preventive medication for people who don’t have HIV has also reshaped the landscape. Pre-exposure prophylaxis, or PrEP, is a daily or injectable medication that dramatically reduces the risk of acquiring HIV. Together, treatment and prevention tools have turned HIV from an inevitably fatal infection into a manageable chronic condition for those who can access care.
Why It’s Not Over
Despite these advances, HIV remains a pandemic because access to treatment is far from universal, and new infections continue at a pace that keeps the virus firmly entrenched worldwide. The tools to end HIV as a public health crisis exist, but the gap between what’s medically possible and what’s actually happening on the ground remains wide, particularly in low-income countries and among marginalized communities even in wealthy ones.
In the United States, the federal Ending the HIV Epidemic initiative set a goal of reducing new infections by 75% by 2025 and 90% by 2030. Meeting that target depends on hitting several benchmarks: getting 95% of people with HIV aware of their status, linking 95% of diagnosed individuals to medical care, achieving viral suppression in 95% of those in treatment, and reaching 50% PrEP coverage among people at elevated risk. These numbers illustrate just how much coordinated effort is still required.
Globally, the picture is similar. UNAIDS has its own 2030 targets, and while progress has been steady, the pandemic continues to outpace the response in several regions. Stigma, funding shortfalls, and inequities in healthcare access remain the biggest barriers. HIV will likely shift from pandemic to endemic status in the coming years in some countries, meaning it will settle into a predictable, lower-level presence rather than disappearing entirely. But for now, with tens of millions of people affected across every continent and over a million new infections each year, HIV is still very much a pandemic.